3D Bioprinting Market

3D Bioprinting Market Size, Share & Trends by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029

Report Code: BT 4971 May, 2024, by marketsandmarkets.com

3D bioprinting market Size, Share & Trends

The size of global 3D bioprinting market in terms of revenue was estimated to be worth $1.3 billion in 2024 and is poised to reach $2.4 billion by 2029, growing at a CAGR of 12.7% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The significant growth in the market is attributable to technological advancement in the 3D bioprinting, increasing partnership and collaboration among public-private entities and significant uptick in the integration of 3D bioprinting technology within pharmaceutical and cosmetic sectors.

3D bioprinting Market Trends

3D bioprinting Market

To know about the assumptions considered for the study, Request for Free Sample Report

3D bioprinting Market

Global 3D bioprinting Market Dynamics

Driver: Growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries

Increasing adoption of 3D bioprinting technology in the pharmaceutical industry has catalyzed substantial growth in the market. This innovative technology enables the precise fabrication of tissues and organs, offering pharmaceutical & biotechnology companies unprecedented opportunities for drug testing, disease modeling, and personalized medicine development. By accurately replicating the complex structures of human tissues, 3D bioprinting allows for more reliable preclinical testing, reducing the need for animal models and accelerating the drug development process. Moreover, it helps create patient-specific organ models for studying diseases and developing tailored treatments, thereby fostering advancements in precision medicine. cosmetology industry, companies leverage bioprinted skin tissue models to conduct more precise evaluations of the safety and efficacy of skincare products. These models replicate the structure and function of human skin, providing an authentic platform to evaluate how products interact with skin cells, tissues, and microbiota. By utilizing bioprinted skin models, companies can streamline product development processes, reduce reliance on animal testing, and ensure that their products adhere to rigorous safety standards while delivering optimal results for consumers. For instance, in June 2023, BICO Group AB (Sweden) Group, which includes CELLINK, Dispendix, ABM, and Sartorius (Germany), entered into a sub-sales and distribution agreement under which Sartorius distributed a range of instruments such as CELLINK’s 3D bioprinting portfolio: BIO X, BIO X6 and BIONOVA X, Dispendix’ liquid handling platform I.DOT MINI, and a wide range of bioinks and reagents from Advanced BioMatrix ( ABM) to their customers in the Asia Pacific.

Restraint: High cost of 3D bioprinters and bioinks

The high cost of 3D bioprinting poses a significant challenge to its widespread adoption and accessibility. This cutting-edge technology, which holds immense promise in revolutionizing healthcare and regenerative medicine, requires sophisticated equipment, specialized materials, and skilled expertise, all of which contribute to its hefty price tag. For example, 3D bioprinters are highly precise machines that use complex designs and advanced systems to accurately place biological materials layer by layer. These printers can cost hundreds of thousands to millions of dollars because of their sophisticated design. Creating the bioinks used in printing, which contain living cells and special materials, requires a lot of research and special processes to make sure they are efficient and safe for the human body

Opportunity: Rising demand for organ transplants

As chronic conditions, such as diabetes, hypertension, and kidney disease, have become more prevalent worldwide, the number of patients requiring organ transplantation continues to rise. These chronic diseases can lead to organ failure or irreversible damage, necessitating life-saving transplant procedures to improve patient outcomes and quality of life. For instance, as of March 2024, there are currently over 103,000 people on the national transplant waiting list and every 8 minutes, another person is added to the list; over 17 people die every year waiting for organ transplants. Similarly, as per the data released by the United Network for Organ Sharing, the number of transplants performed in the US has increased annually, with more than 46,000 organ transplants performed in 2023. Likewise, the number of registrants for organ donation reached 6.7 million in 2023 from 1,087 in 2010 in China

Challenge: Biocompatibility issues and rigorous sterilization protocols

Ensuring biocompatibility is a paramount concern in the field of 3D bioprinting, crucial for seamlessly integrating constructs into living tissues while mitigating potential adverse reactions. This begins with careful material selection, favoring natural polymers and synthetic compounds, which emulate tissue properties while minimizing immunogenicity and toxicity risks. The formulation of bioinks, containing cells within a hydrogel matrix, is pivotal for supporting optimal cell viability, proliferation, and differentiation throughout the printing process.

Biocompatibility issues can also result in organ rejection if the transplanted organ is incompatible with the recipient's body. This occurs when the recipient's immune system identifies the transplanted tissue as foreign and triggers an immune response against it, targeting specific surface proteins known as antigens. Consequently, antibodies are produced, and immune cells are activated to attack and damage the transplanted tissue. This rejection process can occur acutely, shortly after transplantation, or chronically over an extended period. According to the National University Centre for Organ Transplantation at the National University Hospital (NUH), between 30 to 40% of kidney transplants are lost over time to rejection. Addressing biocompatibility concerns is crucial in transplantation to mitigate the risk of rejection and ensure the long-term success of the transplant

3D bioprinting Market Ecosystem

3D bioprinting Market Ecosystem

The 3D bioprinter segment is projected to hold the 3D bioprinting industry dominant position during the forecast period.

Based on component, the 3D bioprinting market is divided into various segments: 3D bioinks, bioprinters, software, and consumables. The 3D bioprinters is segmented into, inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, Microextrusion bioprinters, stereolithography-based bioprinters, and other 3D bioprinters (microvalve bioprinters and tissue fragment bioprinters). The bioin segment is also subdidvided into synthetic, natural and hyrdid bioinks. The 3D bioprinters segment anticipated to account highest share in the market in 2023. lucrative demand for organ transplants coupled with innovation in 3D bioprinting technology serves as driving factor in the market.

North America was the largest regional market for 3D bioprinting industry for both (excluding & including COVID -19 3D bioprinting) in 2023.

The market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2023, North America accounted for the largest share of the 3D bioprinting market and expected to retain dominance throughout the forecast period of 2024-2029. Favorable regulatory policies, reimbursement scenario, presence of key market players in the region are some of the major factors uplifting the market growth in the North America. Europe is likely to grow at significant CAGR owing to various factors such as advancements in bioprinting research and development, increasing healthcare expenditure and government initiatives aimed at expanding 3D bioprinting.

3D bioprinting Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the market include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd. (Israel), regenHU (Switzerland), Aspect Biosystem Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare Inc. (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US), 3D bioprinting solution (Russia), REGEMAT 3D, SL (Spain), Ροietis (France), Sunp Biotech (US), GeSim – Gesellschaft Für Silizium-Mikrosysteme Mbh (Germany), Medprin (China), Voxcell Bioinnovation Inc. (Canada), Prodways (France), Inventia Life Science Pty Ltd (Australia), Upnano Gmbh (Austria), UPM (Finland), and Tissuelabs (Switzerland)

Scope of the 3D Bioprinting Industry:

Report Metric

Details

Market Revenue in 2024

$1.3 billion

Projected Revenue by 2029

$2.4 billion

Revenue Rate

Poised to Grow at a CAGR of 12.7%

Market Driver

Growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries

Market Opportunity

Rising demand for organ transplants

This report categorizes the 3D bioprinting market to forecast revenue and analyze trends in each of the following submarkets:

By Component
  • 3D Bioprinters
    • Microextrusion Bioprinters
    • Inkjet 3D Bioprinters
    • Laser-Assisted Bioprinters
    • Stereolithography-Based Bioprinters
    • Magnetic 3D Bioprinters
    • Other 3D Bioprinters
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks
  • Software
  • Consumables
By Material
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Materials
By Application
  • Research Application
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Applications
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Other Clinical Applications
By End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (ROE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East
    • GCC
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of 3D Bioprinting Industry:

  • In February 2024, BICO Group AB (Cellink) launched DNA Studio 4 Vault, a bioprinting software, providing users with confidence and trust in their documentation, enabling a faster translation from the research lab to the clinic
  • In February 2024, Merck KGaA (Germany) established a distribution center in Brazil with an investment of USD 21.7 million to better serve its Life Science customers for faster deliveries in the region.
  • In April 2023, Aspect Biosystem Ltd (Canada) and Novo Nordisk (Denmark) entered into a collaboration, development, and Licence agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body to deliver a new class of truly disease-modifying treatments for diabetes and obesity.
  • In April 2023, CollPlant Biotechnologies Ltd (Israel) and Stratasys (US) entered into a collaboration for the development of collaborated to develop a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 37)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 SEGMENTS COVERED
                    FIGURE 1 3D BIOPRINTING MARKET: SEGMENTS COVERED
           1.3.2 REGIONS COVERED
                    FIGURE 2 3D BIOPRINTING INDUSTRY: REGIONS COVERED
           1.3.3 YEARS CONSIDERED
           1.3.4 CURRENCY CONSIDERED
    1.4 RESEARCH LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
           1.6.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 42)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primaries
                                FIGURE 4 BREAKDOWN OF PRIMARIES: MARKET
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 5 MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023
          FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
          FIGURE 7 ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023)
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 8 MARKET VALIDATION FROM PRIMARY SOURCES
           2.2.2 MARKET SIZE ESTIMATION, BY SEGMENT
                    FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
           2.3.1 CAGR PROJECTIONS
                    FIGURE 10 MARKET: CAGR PROJECTIONS, 2024–2029
           2.3.2 IMPACT OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
                    TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
    2.4 STUDY ASSUMPTIONS 
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF ECONOMIC RECESSION ON MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 54)
    FIGURE 12 3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION)
    FIGURE 13 3D BIOPRINTING INDUSTRY, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)
    FIGURE 15 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 59)
    4.1 3D BIOPRINTING MARKET OVERVIEW 
          FIGURE 17 RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET
    4.2 NORTH AMERICA: 3D BIOPRINTING INDUSTRY, BY COMPONENT AND COUNTRY (2023) 
          FIGURE 18 US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
    4.3 MARKET, BY COMPONENT, 2024 VS. 2029 
          FIGURE 19 3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD
    4.4 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 63)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 21 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries
                    5.2.1.2 Technological advancements in 3D bioprinting
                    5.2.1.3 Increasing number of public-private partnerships
                    5.2.1.4 Rising investments in medical device R&D
           5.2.2 RESTRAINTS
                    5.2.2.1 Risk of 3D bioprinting failures
                    5.2.2.2 High cost of 3D bioprinters and bioinks
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising demand for organ transplants
                                FIGURE 22 NUMBER OF ORGAN TRANSPLANTS IN US (2024)
                    5.2.3.2 Growing demand for regenerative medicine and stem cell research
           5.2.4 CHALLENGES
                    5.2.4.1 Biocompatibility issues and rigorous sterilization protocols
                    5.2.4.2 Ethical concerns related to use of 3D-bioprinted products
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 23 REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES
    5.4 TECHNOLOGY ANALYSIS 
           5.4.1 KEY TECHNOLOGIES
                    5.4.1.1 Extrusion-based bioprinting
                    5.4.1.2 Inkjet-based bioprinting
                    5.4.1.3 Stereolithography bioprinting
           5.4.2 COMPLEMENTARY TECHNOLOGIES
                    5.4.2.1 Microfluidics and microfabrication
                    5.4.2.2 Nanotechnology and nanomaterials
           5.4.3 ADJACENT TECHNOLOGIES
                    5.4.3.1 3D scanning and imaging
                    5.4.3.2 Organ-on-a-chip
                    5.4.3.3 Organoids technology
    5.5 PRICING ANALYSIS 
           5.5.1 AVERAGE SELLING PRICE OF COMPONENTS, BY REGION
                    TABLE 2 3D BIOPRINTING INDUSTRY: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021–2023
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 24 MARKET: VALUE CHAIN ANALYSIS
    5.7 SUPPLY CHAIN ANALYSIS 
          FIGURE 25 MARKET: SUPPLY CHAIN ANALYSIS
          TABLE 3 MARKET: ROLE IN SUPPLY CHAIN
    5.8 ECOSYSTEM ANALYSIS 
          FIGURE 26 MARKET: ECOSYSTEM MAP
           5.8.1 3D BIOPRINTER VENDORS
                    TABLE 4 3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM
           5.8.2 BIOINK VENDORS
                    TABLE 5 BIOINK VENDORS: ROLE IN ECOSYSTEM
           5.8.3 END USERS
                    TABLE 6 END USERS: ROLE IN ECOSYSTEM
           5.8.4 REGULATORY BODIES
                    TABLE 7 REGULATORY BODIES: ROLE IN ECOSYSTEM
    5.9 PATENT ANALYSIS 
           5.9.1 METHODOLOGY
           5.9.2 NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2024
                    TABLE 8 NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024
           5.9.3 INNOVATION AND PATENT APPLICATION
                    FIGURE 27 NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024
           5.9.4 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS
                    FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
                    FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
                    TABLE 9 MARKET: TOP 12 PATENT OWNERS IN US, 2014–2024
                    TABLE 10 PATENTS IN MARKET, 2023
    5.10 TRADE ANALYSIS 
           5.10.1 IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
                     TABLE 11 IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
           5.10.2 EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)
                     TABLE 12 EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)
           5.10.3 IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
                     TABLE 13 IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019–2023 (USD)
           5.10.4 EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339)
                     TABLE 14 EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019–2023 (USD)
    5.11 KEY CONFERENCES AND EVENTS, 2024–2025 
            TABLE 15 MARKET: KEY CONFERENCES AND EVENTS
    5.12 REGULATORY LANDSCAPE 
           5.12.1 CDRH REGULATIONS ON 3D BIOPRINTING
           5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 INVESTMENT AND FUNDING SCENARIO 
    5.14 PORTER’S FIVE FORCES ANALYSIS 
            FIGURE 30 MARKET: PORTER’S FIVE FORCES ANALYSIS
            TABLE 20 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.14.1 THREAT OF NEW ENTRANTS
           5.14.2 THREAT OF SUBSTITUTES
           5.14.3 BARGAINING POWER OF BUYERS
           5.14.4 BARGAINING POWER OF SUPPLIERS
           5.14.5 INTENSITY OF COMPETITIVE RIVALRY
    5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
           5.15.2 KEY BUYING CRITERIA
                    5.15.2.1 Key buying criteria for top three end users
                                 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET
 
6 3D BIOPRINTING MARKET, BY COMPONENT (Page No. - 102)
    6.1 INTRODUCTION 
          TABLE 23 3D BIOPRINTING INDUSTRY, BY COMPONENT, 2022–2029 (USD MILLION)
    6.2 3D BIOPRINTERS 
          TABLE 24 MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 25 MARKET FOR 3D BIOPRINTERS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 26 NORTH AMERICA: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 27 EUROPE: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 28 ASIA PACIFIC: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 29 LATIN AMERICA: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 30 MIDDLE EAST: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 31 GCC COUNTRIES: MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.1 MICRO EXTRUSION BIOPRINTERS
                    6.2.1.1 Adaptability to different biomaterial types to fuel segment growth
                                TABLE 32 MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 33 NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 34 EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 35 ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 36 LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 37 MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 38 GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.2 INKJET 3D BIOPRINTERS
                    6.2.2.1 High cell viability and low cost to propel market growth
                                TABLE 39 INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 40 NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 41 EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 42 ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 43 LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 44 MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 45 GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.3 LASER-ASSISTED BIOPRINTERS
                    6.2.3.1 Higher resolution and better formation of 3D structures to augment segment growth
                                TABLE 46 LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 47 NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 48 EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 49 ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 50 LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 51 MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 52 GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.4 STEREOLITHOGRAPHY-BASED BIOPRINTERS
                    6.2.4.1 Better printing quality, speed, and cell viability to aid growth
                                TABLE 53 STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 54 NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 55 EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 56 ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 57 LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 58 MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 59 GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.5 MAGNETIC 3D BIOPRINTERS
                    6.2.5.1 Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth
                                TABLE 60 MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 61 NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 62 EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 63 ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 64 LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 65 MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 66 GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.2.6 OTHER 3D BIOPRINTERS
                    TABLE 67 OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 68 NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 69 EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 70 ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 71 LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 72 MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 73 GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.3 BIOINKS 
          TABLE 74 3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 75 MARKET FOR BIOINKS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 76 NORTH AMERICA: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 77 EUROPE: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 78 ASIA PACIFIC: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 79 LATIN AMERICA: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 80 MIDDLE EAST: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 81 GCC COUNTRIES: MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.1 NATURAL BIOINKS
                    6.3.1.1 Increasing investment in R&D and product developments to drive market
                                TABLE 82 NATURAL BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 83 NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 84 EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 85 ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 86 LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 87 MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 88 GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.2 HYBRID BIOINKS
                    6.3.2.1 Higher mechanical strength and greater biocompatibility to boost segment growth
                                TABLE 89 HYBRID BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 90 NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 91 EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 92 ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 93 LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 94 MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 95 GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           6.3.3 SYNTHETIC BIOINKS
                    6.3.3.1 Flexibility, control, and consistency to aid segment growth
                                TABLE 96 SYNTHETIC BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 97 NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 98 EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 99 ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 100 LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 101 MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 102 GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    6.4 SOFTWARE 
           6.4.1 INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH
                    TABLE 103 MARKET FOR SOFTWARE, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 104 NORTH AMERICA: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 105 EUROPE: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 107 LATIN AMERICA: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 108 MIDDLE EAST: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 109 GCC COUNTRIES: MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)
    6.5 CONSUMABLES 
           6.5.1 NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET
                    TABLE 110 MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 111 NORTH AMERICA: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 112 EUROPE: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 113 ASIA PACIFIC: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 114 LATIN AMERICA: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 115 MIDDLE EAST: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 116 GCC COUNTRIES: MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
 
7 3D BIOPRINTING MARKET, BY MATERIAL (Page No. - 156)
    7.1 INTRODUCTION 
          TABLE 117 3D BIOPRINTING INDUSTRY, BY MATERIAL, 2022–2029 (USD MILLION)
    7.2 LIVING CELLS 
           7.2.1 INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH
                    TABLE 118 MARKET FOR LIVING CELLS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 119 NORTH AMERICA: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 120 EUROPE: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 121 ASIA PACIFIC: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 122 LATIN AMERICA: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 123 MIDDLE EAST: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 124 GCC COUNTRIES: MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.3 HYDROGELS 
           7.3.1 INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH
                    TABLE 125 MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 126 NORTH AMERICA: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 127 EUROPE: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 128 ASIA PACIFIC: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 129 LATIN AMERICA: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 130 MIDDLE EAST: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 131 GCC COUNTRIES: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
    7.4 EXTRACELLULAR MATRICES 
           7.4.1 INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH
                    TABLE 132 MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 133 NORTH AMERICA: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 134 EUROPE: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 135 ASIA PACIFIC: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 136 LATIN AMERICA: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 137 MIDDLE EAST: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 138 GCC COUNTRIES: MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)
    7.5 OTHER MATERIALS 
          TABLE 139 MARKET FOR OTHER MATERIALS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 140 NORTH AMERICA: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 141 EUROPE: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 142 ASIA PACIFIC: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 143 LATIN AMERICA: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 144 MIDDLE EAST: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 145 GCC COUNTRIES: MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)
 
8 3D BIOPRINTING MARKET, BY APPLICATION (Page No. - 175)
    8.1 INTRODUCTION 
          TABLE 146 3D BIOPRINTING INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
    8.2 RESEARCH APPLICATIONS 
          TABLE 147 MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 148 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 149 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 150 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 151 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 152 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 153 MIDDLE EAST: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 154 GCC COUNTRIES: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
           8.2.1 DRUG RESEARCH
                    8.2.1.1 Better precision and greater customization facilities in pharmaceutical sector to drive segment
                                TABLE 155 DRUG RESEARCH MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 156 NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 157 EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 158 ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 159 LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 160 MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 161 GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           8.2.2 REGENERATIVE MEDICINE
                    8.2.2.1 Growing demand for organ transplants to support segment growth
                                TABLE 162 REGENERATIVE MEDICINE MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 163 NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 164 EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 165 ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 166 LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 167 MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 168 GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           8.2.3 3D CELL CULTURE
                    8.2.3.1 Rising investments in cell culture development to augment segment growth
                                TABLE 169 3D CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 170 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 171 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 172 ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 174 MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 175 GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
    8.3 CLINICAL APPLICATIONS 
          TABLE 176 MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 177 MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
          TABLE 178 NORTH AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 179 EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 180 ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 181 LATIN AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 182 MIDDLE EAST: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 183 GCC COUNTRIES: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
           8.3.1 SKIN
                    8.3.1.1 Rising applications in skincare and cosmetics to propel segment growth
                                TABLE 184 SKIN MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 185 NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 186 EUROPE: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 187 ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 188 LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 189 MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 190 GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           8.3.2 BONE & CARTILAGE
                    8.3.2.1 Increasing incidence of musculoskeletal conditions to support segment growth
                                TABLE 191 BONE & CARTILAGE MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 192 NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 193 EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 194 ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 195 LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 196 MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 197 GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           8.3.3 BLOOD VESSELS
                    8.3.3.1 Growing focus on research activities to aid segment growth
                                TABLE 198 BLOOD VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
                                TABLE 199 NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 200 EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 201 ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 202 LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 203 MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                                TABLE 204 GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
           8.3.4 OTHER CLINICAL APPLICATIONS
                    TABLE 205 OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 206 NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 207 EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 208 ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 209 LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 210 MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 211 GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
9 3D BIOPRINTING MARKET, BY END USER (Page No. - 213)
    9.1 INTRODUCTION 
          TABLE 212 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
    9.2 ACADEMIC & RESEARCH INSTITUTES 
           9.2.1 RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET
                    TABLE 213 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 214 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 215 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 216 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 217 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 218 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 219 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
    9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH
                    TABLE 220 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 221 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 222 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 223 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 224 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 225 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 226 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
    9.4 HOSPITALS 
           9.4.1 RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH
                    TABLE 227 MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
                    TABLE 228 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 229 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 230 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 231 LATIN AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 232 MIDDLE EAST: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 233 GCC COUNTRIES: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
 
10 3D BIOPRINTING MARKET, BY REGION (Page No. - 228)
     10.1 INTRODUCTION 
             TABLE 234 3D BIOPRINTING INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
     10.2 NORTH AMERICA 
             FIGURE 31 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
             TABLE 235 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 236 NORTH AMERICA: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
             TABLE 237 NORTH AMERICA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 238 NORTH AMERICA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 239 NORTH AMERICA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
             TABLE 240 NORTH AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 241 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 242 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 243 NORTH AMERICA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.2.1 NORTH AMERICA: RECESSION IMPACT
             10.2.2 US
                        10.2.2.1 US to dominate North American 3D bioprinting market during forecast period
                                      TABLE 244 US: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 245 US: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 246 US: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 247 US: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 248 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 249 US: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 250 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 251 US: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Increased number of public-private partnerships for life science research to drive market
                                      TABLE 252 CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 253 CANADA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 254 CANADA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 255 CANADA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 256 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 257 CANADA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 258 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 259 CANADA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.3 EUROPE 
             TABLE 260 EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 261 EUROPE: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
             TABLE 262 EUROPE: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 263 EUROPE: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 264 EUROPE: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
             TABLE 265 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 266 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 267 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 268 EUROPE: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.1 EUROPE: RECESSION IMPACT
             10.3.2 GERMANY
                        10.3.2.1 Rising healthcare expenditure and increasing demand for organ transplants to favor market growth
                                      TABLE 269 GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 270 GERMANY: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 271 GERMANY: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 272 GERMANY: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 273 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 274 GERMANY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 275 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 276 GERMANY: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Rising prevalence of chronic diseases and increasing R&D activities to drive market
                                      TABLE 277 UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 278 UK: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 279 UK: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 280 UK: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 281 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 282 UK: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 283 UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 284 UK: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Increasing availability of advanced medical technologies to support market growth
                                      TABLE 285 FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 286 FRANCE: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 287 FRANCE: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 288 FRANCE: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 289 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 290 FRANCE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 291 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 292 FRANCE: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Increased research investment and funding to support market growth
                                      TABLE 293 ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 294 ITALY: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 295 ITALY: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 296 ITALY: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 297 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 298 ITALY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 299 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 300 ITALY: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Favorable investment scenario and increase in number of research centers to aid market growth
                                      TABLE 301 SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 302 SPAIN: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 303 SPAIN: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 304 SPAIN: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 305 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 306 SPAIN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 307 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 308 SPAIN: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.3.7 REST OF EUROPE
                        TABLE 309 REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 310 REST OF EUROPE: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 311 REST OF EUROPE: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 312 REST OF EUROPE: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 313 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 314 REST OF EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 315 REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 316 REST OF EUROPE: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.4 ASIA PACIFIC 
             FIGURE 32 ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT
             TABLE 317 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 318 ASIA PACIFIC: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
             TABLE 319 ASIA PACIFIC: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 320 ASIA PACIFIC: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 321 ASIA PACIFIC: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
             TABLE 322 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 323 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 324 ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 325 ASIA PACIFIC: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth
                                      TABLE 326 CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 327 CHINA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 328 CHINA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 329 CHINA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 330 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 331 CHINA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 332 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 333 CHINA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.4.2 JAPAN
                        10.4.2.1 Advancements in healthcare infrastructure to support market growth
                                      TABLE 334 JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 335 JAPAN: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 336 JAPAN: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 337 JAPAN: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 338 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 339 JAPAN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 340 JAPAN: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 341 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Increasing developments in biopharmaceutical industry to propel market growth
                                      TABLE 342 INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 343 INDIA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 344 INDIA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 345 INDIA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 346 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 347 INDIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 348 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 349 INDIA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 Rising private and public funding for research activities to drive market
                                      TABLE 350 AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 351 AUSTRALIA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 352 AUSTRALIA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 353 AUSTRALIA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 354 AUSTRALIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 355 AUSTRALIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 356 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 357 AUSTRALIA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Favorable government policies and high investments from private sector to fuel market growth
                                      TABLE 358 SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 359 SOUTH KOREA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 360 SOUTH KOREA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 361 SOUTH KOREA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 362 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 363 SOUTH KOREA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 364 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 365 SOUTH KOREA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
             10.4.7 ASIA PACIFIC: RECESSION IMPACT
                        TABLE 366 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 367 REST OF ASIA PACIFIC: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 368 REST OF ASIA PACIFIC: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 369 REST OF ASIA PACIFIC: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 370 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 371 REST OF ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 372 REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 373 REST OF ASIA PACIFIC: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.5 LATIN AMERICA 
             TABLE 374 LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 375 LATIN AMERICA: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
             TABLE 376 LATIN AMERICA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 377 LATIN AMERICA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 378 LATIN AMERICA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
             TABLE 379 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 380 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 381 LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 382 LATIN AMERICA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.5.1 LATIN AMERICA: RECESSION IMPACT
             10.5.2 BRAZIL
                        10.5.2.1 Brazil to hold largest share in Latin American market
                                      TABLE 383 BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 384 BRAZIL: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 385 BRAZIL: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 386 BRAZIL: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 387 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 388 BRAZIL: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 389 BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 390 BRAZIL: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.5.3 MEXICO
                        10.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth
                                      TABLE 391 MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 392 MEXICO: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 393 MEXICO: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 394 MEXICO: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 395 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 396 MEXICO: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 397 MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 398 MEXICO: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                        TABLE 399 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 400 REST OF LATIN AMERICA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 401 REST OF LATIN AMERICA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 402 REST OF LATIN AMERICA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 403 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 404 REST OF LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 405 REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 406 REST OF LATIN AMERICA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.6 MIDDLE EAST 
             TABLE 407 MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
             TABLE 408 MIDDLE EAST: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
             TABLE 409 MIDDLE EAST: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 410 MIDDLE EAST: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 411 MIDDLE EAST: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
             TABLE 412 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
             TABLE 413 MIDDLE EAST: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 414 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
             TABLE 415 MIDDLE EAST: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.6.1 MIDDLE EAST: RECESSION IMPACT
             10.6.2 GCC COUNTRIES
                        TABLE 416 GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                        TABLE 417 GCC COUNTRIES: MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 418 GCC COUNTRIES: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 419 GCC COUNTRIES: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 420 GCC COUNTRIES: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 421 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 422 GCC COUNTRIES: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 423 GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 424 GCC COUNTRIES: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                        10.6.2.1 Saudi Arabia
                                     10.6.2.1.1 Increasing government investments in healthcare and growing pharmaceuticals industry to support market growth
                                                      TABLE 425 SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                                      TABLE 426 SAUDI ARABIA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 427 SAUDI ARABIA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 428 SAUDI ARABIA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                                      TABLE 429 SAUDI ARABIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                                      TABLE 430 SAUDI ARABIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 431 SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 432 SAUDI ARABIA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                        10.6.2.2 United Arab Emirates
                                     10.6.2.2.1 Increased R&D expenditure and advanced healthcare infrastructure to boost market growth
                                                      TABLE 433 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                                      TABLE 434 UNITED ARAB EMIRATES: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 435 UNITED ARAB EMIRATES: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 436 UNITED ARAB EMIRATES: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                                      TABLE 437 UNITED ARAB EMIRATES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                                      TABLE 438 UNITED ARAB EMIRATES: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 439 UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                                      TABLE 440 UNITED ARAB EMIRATES: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
                        10.6.2.3 Rest of GCC countries
                                      TABLE 441 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                                      TABLE 442 REST OF GCC COUNTRIES: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 443 REST OF GCC COUNTRIES: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 444 REST OF GCC COUNTRIES: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                                      TABLE 445 REST OF GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                      TABLE 446 REST OF GCC COUNTRIES: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 447 REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                      TABLE 448 REST OF GCC COUNTRIES: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.6.3 REST OF MIDDLE EAST
                        TABLE 449 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 450 REST OF MIDDLE EAST: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 451 REST OF MIDDLE EAST: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 452 REST OF MIDDLE EAST: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 453 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 454 REST OF MIDDLE EAST: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 455 REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 456 REST OF MIDDLE EAST: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
     10.7 AFRICA 
             10.7.1 GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
                        TABLE 457 AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)
                        TABLE 458 AFRICA: MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 459 AFRICA: MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 460 AFRICA: MARKET, BY MATERIAL, 2022–2029 (USD MILLION)
                        TABLE 461 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                        TABLE 462 AFRICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 463 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                        TABLE 464 AFRICA: 3D BIOPRINTING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
             10.7.2 AFRICA: RECESSION IMPACT
 
11 COMPETITIVE LANDSCAPE (Page No. - 362)
     11.1 INTRODUCTION 
     11.2 KEY STRATEGIES/RIGHT TO WIN 
             FIGURE 33 3D BIOPRINTING MARKET: STRATEGIES ADOPTED
     11.3 REVENUE ANALYSIS 
             FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2021–2023)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
             TABLE 465 3D BIOPRINTING INDUSTRY: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 36 3D BIOPRINTING INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
             11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                        11.5.5.1 Overall footprint
                                      FIGURE 37 3D BIOPRINTING INDUSTRY: OVERALL FOOTPRINT
                        11.5.5.2 Component footprint
                                      TABLE 466 3D BIOPRINTING INDUSTRY: COMPONENT FOOTPRINT
                        11.5.5.3 Regional footprint
                                      TABLE 467 3D BIOPRINTING INDUSTRY: REGIONAL FOOTPRINT
                        11.5.5.4 Material footprint
                                      TABLE 468 3D BIOPRINTING INDUSTRY: MATERIAL FOOTPRINT
                        11.5.5.5 Application footprint
                                      TABLE 469 3D BIOPRINTING INDUSTRY: APPLICATION FOOTPRINT
     11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 RESPONSIVE COMPANIES
             11.6.3 DYNAMIC COMPANIES
             11.6.4 STARTING BLOCKS
                        FIGURE 38 3D BIOPRINTING INDUSTRY: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
             11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
                        TABLE 470 3D BIOPRINTING INDUSTRY: DETAILED LIST OF KEY START-UPS/SMES
                        TABLE 471 3D BIOPRINTING INDUSTRY: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
     11.7 VALUATION AND FINANCIAL METRICS 
             FIGURE 39 EV/EBITDA OF KEY VENDORS
             FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
     11.8 BRAND/PRODUCT COMPARISON 
             FIGURE 41 3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON
             11.8.1 BICO GROUP AB
             11.8.2 REGENHU
             11.8.3 ROKIT HEALTHCARE, INC.
     11.9 COMPETITIVE SCENARIO 
             11.9.1 PRODUCT LAUNCHES
                        TABLE 472 3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024
             11.9.2 DEALS
                        TABLE 473 3D BIOPRINTING MARKET: DEALS, JANUARY 2021–MARCH 2024
             11.9.3 EXPANSIONS
                        TABLE 474 3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024
             11.9.4 OTHER DEVELOPMENTS
                        TABLE 475 3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024
 
12 COMPANY PROFILES (Page No. - 380)
(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
     12.1 KEY PLAYERS 
             12.1.1 BICO GROUP AB
                        TABLE 476 BICO GROUP AB: COMPANY OVERVIEW
                        FIGURE 42 BICO GROUP AB: COMPANY SNAPSHOT (2023)
                        TABLE 477 BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 478 BICO GROUP AB: PRODUCT LAUNCHES
                        TABLE 479 BICO GROUP AB: DEALS
                        TABLE 480 BICO GROUP AB: EXPANSIONS
                        TABLE 481 BICO GROUP AB: OTHER DEVELOPMENTS
             12.1.2 3D SYSTEMS, INC.
                        TABLE 482 3D SYSTEMS, INC.: COMPANY OVERVIEW
                        FIGURE 43 3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
                        TABLE 483 3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 484 3D SYSTEMS, INC.: DEALS
                        TABLE 485 3D SYSTEMS, INC.: EXPANSIONS
             12.1.3 MERCK KGAA
                        TABLE 486 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
                        TABLE 487 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 488 MERCK KGAA: EXPANSIONS
             12.1.4 ORGANOVO HOLDINGS INC.
                        TABLE 489 ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW
                        FIGURE 45 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023)
                        TABLE 490 ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 491 ORGANOVO HOLDINGS INC.: DEALS
             12.1.5 COLLPLANT BIOTECHNOLOGIES LTD.
                        TABLE 492 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW
                        FIGURE 46 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)
                        TABLE 493 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 494 COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 495 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES
                        TABLE 496 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS
             12.1.6 REGENHU
                        TABLE 497 REGENHU: COMPANY OVERVIEW
                        TABLE 498 REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             12.1.7 ASPECT BIOSYSTEMS LTD.
                        TABLE 499 ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW
                        TABLE 500 ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 501 ASPECT BIOSYSTEMS LTD.: DEALS
             12.1.8 ADVANCED SOLUTIONS LIFE SCIENCES, LLC
                        TABLE 502 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW
                        TABLE 503 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 504 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS
                        TABLE 505 ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS
             12.1.9 CYFUSE BIOMEDICAL K.K.
                        TABLE 506 CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW
                        TABLE 507 CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             12.1.10 ROKIT HEALTHCARE, INC.
                        TABLE 508 ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW
                        TABLE 509 ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             12.1.11 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.
                        TABLE 510 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
                        TABLE 511 HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             12.1.12 FOLDINK
                        TABLE 512 FOLDINK: COMPANY OVERVIEW
                        TABLE 513 FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             12.1.13 BRINTER
                        TABLE 514 BRINTER: COMPANY OVERVIEW
                        TABLE 515 BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 516 BRINTER: DEALS
                        TABLE 517 BRINTER: EXPANSIONS
             12.1.14 3D BIOPRINTING SOLUTIONS
                        TABLE 518 3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW
                        TABLE 519 3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS 
             12.2.1 REGEMAT 3D, SL
                        TABLE 520 REGEMAT 3D, SL: COMPANY OVERVIEW
             12.2.2 ΡΟΙΕTIS
                        TABLE 521 POIETIS: COMPANY OVERVIEW
             12.2.3 SUNP BIOTECH
                        TABLE 522 SUNP BIOTECH: COMPANY OVERVIEW
             12.2.4 GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH
                        TABLE 523 GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW
             12.2.5 MEDPRIN
                        TABLE 524 MEDPRIN: COMPANY OVERVIEW
             12.2.6 VOXCELL BIOINNOVATION INC.
                        TABLE 525 VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW
             12.2.7 PRODWAYS
                        TABLE 526 PRODWAYS: COMPANY OVERVIEW
             12.2.8 INVENTIA LIFE SCIENCE PTY LTD.
                        TABLE 527 INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW
             12.2.9 UPNANO GMBH
                        TABLE 528 UPNANO GMBH: COMPANY OVERVIEW
             12.2.10 UPM
                        TABLE 529 UPM: COMPANY OVERVIEW
             12.2.11 TISSUELABS
                        TABLE 530 TISSUELABS: COMPANY OVERVIEW
 
13 APPENDIX (Page No. - 446)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the 3D bioprinting market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the 3D bioprinting market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration (US), National Health Service (NHS), ClinicalTrials.Gov, National Institutes of Health (NIH), Elsevier, Canadian Manufacturers & Exporters (CME) , Ministry of Science and Technology (China), Dubai Health Authority (DHA), South African Department of Science and Technology (DST), Ministry of Food and Drug Safety (South Korea), Organ Procurement and Transplantation Network (OPTN), OrganDonor.gov, Eurotransplant (ET), Centre for Commercialization of Regenerative Medicine (CCRM), Networks of Centres of Excellence (NCE), Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), Advanced Research Projects Agency for Health (ARPA-H), American Public Health Association (APHA), American Public Health Association (APHA), National Kidney Foundation (NKF), National University Centre for Organ Transplantation (NUCOT), ACS Journals; Corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global 3D bioprinting market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

3D bioprinting Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the 3D bioprinting market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The major players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the 3D bioprinting business of players operating in the market have been determined through secondary research and primary analysis.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global 3D bioprinting Market Size: Bottom-Up Approach

3D bioprinting Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach-

3D bioprinting Market Size, and Share

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Bioprinting is a technology where bioinks and biomaterials, mixed with cells, are 3D printed, often to construct living tissue models. Bioprinting, in general, is defined as the deposition of living cells in combination with biological substances, such as collagen, fibrin, and gelatin, for the growth of complete tissues and organs. The 3D bioprinting process starts with the creation of an architectural design that is based on the fundamental composition of the organs or target tissues and makes use of living cells, molecules, and biomaterials to produce complex living and non-living biological products.

Key Stakeholders

  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Research and Development (R&D) Companies
  • 3D Cell Culture Product Manufacturers

Report Objectives

  • To define, describe, and forecast the 3D bioprinting market based on component, material, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall 3D Bioprinting market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the market size of the segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategies, including trends/disruptions impacting customers’ business, pricing analysis, supply/value chain analysis, ecosystem analysis, technology analysis, patent analysis, trade analysis, key conferences & events in 2024-2025, key stakeholders & buying criteria, and investment & funding scenario.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the 3D bioprinting Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4971
Published ON
May, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Bioprinting Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback